Skip to main content.

Biology

Picture of Chris  Woolston

Looking back at a deceased column: The Healthy Skeptic.

Picture of Nathanael Johnson

A new hypothesis on autism, more data on the "fat genes," the problem of oral health, rethinking autonomy for the mentally ill and more from our Daily Briefing.

Picture of William Heisel

Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.

Picture of William Heisel

When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.

Picture of Nalea J. Ko

It is three in the morning and Philip, 27, wakes up from a nightmare that he soon forgets. Vivid dreams and dizziness are recurring experiences, side effects he attributes to taking Atripla, a pill he consumes daily because he has AIDS.

Picture of Gergana Koleva

A confluence of factors including an inflexible regulatory enviroment that discourages research and discovery, a paltry research pipeline for drugs for the most serious illnesses, and a tendency for physicians to unnecessarily prescribe antibiotics for routine aches and pains is largely responsible for the rise of antibiotic-resistant infections in humans, speakers at a major conference on infectious diseases this week announced.

Picture of Barbara Feder Ostrov

A year after the Fukushima nuclear crisis, restaurant health ratings and salmonella outbreaks, hospital infection news and more from our Daily Briefing.

Picture of Kate Long

To battle obesity, West Virginia Schools teachers are implementing 15 extra minutes of physical activity into each day.

Picture of Gergana Koleva

Regenerative Sciences, a medical company that pioneered a procedure to treat orthopedic injuries using patients’ own stem cells, is fighting the Food and Drug Administration tooth and nail over a claim that human cells should be federally regulated as drugs, in a landmark case that has far-reaching implications for the future of regenerative medicine.

Picture of Barbara Feder Ostrov

Toxic hair straightening, a new drug for cystic fibrosis, a religious battle over birth control and more from our Daily Briefing.

Pages

Announcements

Ready to take your journalism to a new level by honing your data analysis and visualization skills?  We're offering our highly acclaimed annual Data Fellowship through Zoom from Nov. 30-Dec. 4.

Do you have a great idea for a potentially impactful reporting project on a health challenge in California?  Our 2020 Impact Fund can provide financial support and six months of mentoring.

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth